Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Update on the Latest Developments in Viral and Non-Viral Vector Manufacturing
Guest Editor:
Jan Thirkettle, Chief Executive Officer at Transine Therapeutics
Jan Thirkettle
Chief Executive Officer at Transine Therapeutics
November 2018
Sponsor
Co-sponsor
Download full spotlight
Standardizing viral vector manufacture: maximizing production with the TRiP System
TM
D Farley
2 January 2019
Innovator Insight
Read more
Evaluation of Poros AAVX Pan-Affinity Resin for rAAV purification and cGMP Manufacturing
Daniel Hurwit, Scientist at Bristol-Myers Squibb
18 December 2018
Webinar
Watch now
Transmission Electron Microscopy: a Critical Component of the Vector Analytical Toolkit
V Carvalho
17 December 2018
Interview
Read more
Joined-up thinking: success criteria for tomorrow’s viral vector production platforms
P Vanek
17 December 2018
Podcast
Listen now
The latest developments in viral and non-viral vector manufacturing
J Thirkettle
10 December 2018
Foreword
Read more
The Growing Promise of Gene Therapy Approaches
J Grieger,
R Snyder,
J Samulski
et al.
10 December 2018
Conference Insight
Read more
Update on the Sleeping Beauty transposon system for therapeutic applications
S Narayanavari
6 December 2018
Editorial
Read more
Joined-up thinking: success criteria for tomorrow’s viral vector production platforms
P Vanek
3 December 2018
Interview
Read more
Transmission Electron Microscopy: a Critical Component of the Vector Analytical Toolkit
V Carvahlo
3 December 2018
Podcast
Listen now
Lentiviral vectors in hematopoietic stem cell therapies: mainstay technology, or simply a bridge to gene editing?
M Moore,
J Counsell
30 November 2018
Editorial
Read more
AAV meets exosomes: at the cutting edge of cardiovascular gene therapy
R Hajjar
30 November 2018
Interview
Read more
Keeping viral vector manufacturing in-house: strategic considerations for gene therapy biotechs
T Miller
30 November 2018
Interview
Read more
Capacity or capability? Getting your priorities right in viral vector manufacturing
J Thirkettle
30 November 2018
Interview
Read more
Challenges and progress in lentiviral vector bioprocessing
E Macchiarulo,
P Bassett,
M Dudley
30 November 2018
Expert Insight
Read more
Applying learnings from the bioprocess development of Luxturna™
J Wright
30 November 2018
Interview
Read more
Scaling up gene therapy manufacturing for multinational pivotal trials & commercialization
K Regulski
30 November 2018
Interview
Read more
Scalable, helper virus-free AAV production with stable CAP-GT producer cell lines
Nicole Faust, CEO at CEVEC Pharmaceuticals GmbH
8 November 2018
Webinar
Watch now
×
Please enter your email to register
Register